CSI Market
Sign In | Register

Bio Key International Inc (BKYI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BKYI Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Bio Key International Inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-0.78
Depreciation & amortization0.03
Amortization of Other Assets0.15
Increase (Decrease) in Deferred Revenue0.05
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-1.60
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.08
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.05
Stock Issued During Period Value Issued For Directors Fees-
Increase Decrease In Software License Rights-
Amortization Of Software License Rights-
Stock Based Fees To Directors And Consulants-
Stock Based Fees To Directors And Consultants0.02
Capitalized Contract Cost Amortization0.13
Change In Operating Lease Rightofuse Assets-
Operating Lease Right Of Use Asset Amortization Expense-
Operating Lease Rightofuse Asset Amortization Expense Reversal Of Expense-
Reserve For Investment Security-
Reserve For Note Receivable-
Allowance For Doubtful Accounts Receivable Write Offs-
Increase Decrease In Capitalized Contract Costs-0.06
Goodwill Acquired During Period-
Noncash Or Part Noncash Acquisition Accrued Expenses And Other Liabilities Assumed-
Noncash Or Part Noncash Acquisition Stock Issued Amount-
Provision For Doubtful Accounts Including Writeoff-
Increase Decrease In Right Of Use Assets-0.01
Income taxes0.00
Gain (Loss) on Sale of Derivatives0.00
Accounts Receivable0.29
Increase (Decrease) in Accounts Payable-0.10
Increase (Decrease) in Accrued Liabilities-0.16
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.07
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.71
Discontinued operations0.00
Net Cash flow from Operating Activities-1.20
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Held-to-maturity Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments to Acquire Loans Receivable0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.08
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.04
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.01
Proceeds From Employee Stock Purchase Plan0.00
Payments For Legal Fees-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations0.44
Payments of Ordinary Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-1.20
Total Cash Flow-1.32
4 historic quarters locked

Sign in to unlock the full Bio Key International Inc cash flow history.

Sign In Create Free Account

About Bio Key International Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-027723

Figures are derived from filed reports and may be restated. Historical data is subject to revision.